Biotech & MedTech
-
Valeo Pharma’s Steve Saviuk talks about the US$40M non-dilutive financing from Sagard Healthcare Partners
In this InvestorIntel interview with host Tracy Weslosky, Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO and…
-
Zentek CEO Greg Fenton talks about bringing new antimicrobial HVAC filters to market
In this InvestorIntel interview with host Tracy Weslosky, Zentek Ltd.’s (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director Greg…
-
Anthony Tennyson of Awakn Life Sciences on commercializing its addiction treatment therapeutics
In this InvestorIntel interview with host Tracy Weslosky, Awakn Life Sciences Corp.’s (NEO: AWKN | OTCQB: AWKNF) Co-Founder &…
-
Steve Saviuk of Valeo Pharma talks about revenue growth following impressive market gains
In this InvestorIntel interview with host Tracy Weslosky, Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO…
-
Valeo Pharma revenues jump on increased market share from growing drug portfolio
Valeo Pharma Inc. (TSX: VPH | OTCQB: VPHIF) is a Canadian pharmaceutical company that is seeing significant success…
-
David Regan of Sona Nanotech talks about developments in its unique gold nanorod technology
In this InvestorIntel interview with host Tracy Weslosky, Sona Nanotech Inc.’s (CSE: SONA | OTCQB: SNANF) CEO David…
-
Addiction may have met its match in Awakn Life Sciences therapeutics
Addiction is one of the biggest unmet medical needs globally with substance and behavioral addictions affecting a significant…
-
Greg Fenton of Zentek discusses recent news including a NASDAQ listing and a distribution agreement
In this InvestorIntel interview with host Tracy Weslosky, Zentek Ltd. (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director…
